Histopathological atlas and proposed classification for melanocytic lesions in Tyr: NRasQ61K; Cdkn2a-/- transgenic mice

Pigment Cell and Melanoma Research

Volumn 26, Issue 5, 2013, Pages 735-742

  Campagne, Cécile ^a,b,i   Reyes Gomez, Edouard ^a,b   Battistella, Maxime ^c,d,e   Bernex, Florence ^a,b,h   Château Joubert, Sophie ^b   Huet, Hélène ^b   Beermann, Friedrich ^f   Aubin Houzelstein, Geneviève ^a,b,g   Egidy, Giorgia ^a,b,g  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b UNIVERSITÉ PARIS EST   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f EPFL   (Switzerland)

^g INSTITUT PASTEUR   (France)

^h INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DIFFERENTIATION ANTIGEN; GLUTAMINE; LYSINE; MELAN A; MELANIN; PIGMENT; PROTEIN P14; PROTEIN P16; TUMOR SUPPRESSOR PROTEIN; TYROSINE;

ARTICLE; CAPILLARY; CHROMATIN; CODON; CUTANEOUS MELANOMA; CYTOPLASM; DENDRITIC CELL; DERMIS; DISEASE CLASSIFICATION; DYSPLASTIC NEVUS; EXON; GENE MUTATION; HAIR FOLLICLE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; INFLAMMATORY CELL; LYMPH NODE; LYMPH NODE METASTASIS; MACROPHAGE; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA CELL; METASTASIS; MITOSIS; MOLECULAR PATHOLOGY; NECROSIS; NONHUMAN; NUCLEOLUS; ONCOGENE N RAS; PIGMENTATION; SKIN CELL; STELLATE CELL; TUMOR GROWTH; ULCER;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; MELANOCYTES; MELANOMA; MICE; MICE, TRANSGENIC; MUTATION; RAS PROTEINS; SKIN NEOPLASMS;

EID: 84883004469     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12115     Document Type: Article

References (29)

1. Ackermann, J., Frutschi, M., Kaloulis, K., Mckee, T., Trumpp, A., and Beermann, F. (2005). Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 65, 4005-4011.
2. Alikhan, A., Ibrahimi, O.A., and Eisen, D.B. (2012). Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. J. Am. Acad. Dermatol. 67, 495 e1-495 e17; quiz 512-4.
3. Barnhill, R.L., and Gupta, K. (2009). Unusual variants of malignant melanoma. Clin. Dermatol. 27, 564-587.
4. Brat, D.J., Giannini, C., Scheithauer, B.W., and Burger, P.C. (1999). Primary melanocytic neoplasms of the central nervous systems. Am. J. Surg. Pathol. 23, 745-754.
5. Das, P., Kumar, N., Ahuja, A., Jain, A., Ray, R., Sarkar, C., and Gupta, S.D. (2010). Primary malignant melanoma at unusual sites: an institutional experience with review of literature. Melanoma Res. 20, 233-239.
6. Devitt, B., Liu, W., Salemi, R., Wolfe, R., Kelly, J., Tzen, C.Y., Dobrovic, A., and Mcarthur, G. (2011). Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma. Pigment Cell. Melanoma. Res. 24, 666-672.
7. Dhomen, N., Reis-Filho, J.S., Da Rocha Dias, S., Hayward, R., Savage, K., Delmas, V., Larue, L., Pritchard, C., and Marais, R. (2009). Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15, 294-303.
8. Dohse, L., and Ferringer, T. (2010). Nodal blue nevus: a pitfall in lymph node biopsies. J. Cutan. Pathol. 37, 102-104.
9. Ellerhorst, J.A., Greene, V.R., Ekmekcioglu, S. et al. (2011). Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Clin. Cancer Res. 17, 229-235.
10. Funk, J.O., Schiller, P.I., Barrett, M.T., Wong, D.J., Kind, P., and Sander, C.A. (1998). p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma. J. Cutan. Pathol. 25, 291-296.
11. Grafstrom, E., Egyhazi, S., Ringborg, U., Hansson, J., and Platz, A. (2005). Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival. Clin. Cancer Res. 11, 2991-2997.
12. Holt, J.B., Sangueza, O.P., Levine, E.A., Shen, P., Bergman, S., Geisinger, K.R., and Creager, A.J. (2004). Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi. Am. J. Clin. Pathol. 121, 58-63.
13. Ioachim, H.L. (2009). Dermatophatic lymphadenopathy. In Lymph node pathology, H.L., Ioachim, and L.J., Medeiros, eds. (Philadelphia: Lippincott & Williams & Williams), pp. 223-226.
14. Kusters-Vandevelde, H.V., Klaasen, A., Kusters, B., Groenen, P.J., Van Engen-Van Grunsven, I.A., Van Dijk, M.R., Reifenberger, G., Wesseling, P., and Blokx, W.A. (2010). Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol. 119, 317-323.
15. Lee, J.H., Choi, J.W., and Kim, Y.S. (2011). Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br. J. Dermatol. 164, 776-784.
16. Lindsay, C.R., Lawn, S., Campbell, A.D. et al. (2011). P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. Nat. Commun. 2, 555.
17. Milagre, C., Dhomen, N., Geyer, F.C., Hayward, R., Lambros, M., Reis-Filho, J.S., and Marais, R. (2010). A mouse model of melanoma driven by oncogenic KRAS. Cancer Res. 70, 5549-5557.
18. Misago, N., Nagase, K., Toda, S., Shinoda, Y., Koba, S., and Narisawa, Y. (2008). Cellular blue nevus with nevus cells in a sentinel lymph node. Eur. J. Dermatol. 18, 586-589.
19. Murali, R., Mccarthy, S.W., and Scolyer, R.A. (2009). Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv. Anat. Pathol. 16, 365-382.
20. Percy, D.H., and Barthold, S.W. (2007). Introduction. In The mouse, B.P., Professional, ed. (Ames, IA: Blackwell Publishing), pp. 4-6.
21. Phadke, P.A., and Zembowicz, A. (2011). Blue nevi and related tumors. Clin. Lab. Med. 31, 345-358.
22. Plonka, P.M., Passeron, T., Brenner, M. et al. (2009). What are melanocytes really doing all day long.? Exp. Dermatol. 18, 799-819.
23. Sellers, R.S., and Ward, J.M. (2012). Toward a better understanding of mouse models of disease. Vet. Pathol. 49, 4.
24. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and Depinho, R.A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
25. Shakhova, O., Zingg, D., Schaefer, S.M. et al. (2012). Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat. Cell Biol. 14, 882-890.
26. Takeuchi, S., Takahashi, A., Motoi, N. et al. (2010). Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo. Cancer Res. 70, 9381-9390.
27. Walker, G.J., Soyer, H.P., Terzian, T., and Box, N.F. (2011). Modelling melanoma in mice. Pigment Cell. Melanoma. Res. 24, 1158-1176.
28. Yajima, I., and Larue, L. (2008). The location of heart melanocytes is specified and the level of pigmentation in the heart may correlate with coat color. Pigment Cell. Melanoma. Res. 21, 471-476.
29. Zembowicz, A., and Phadke, P.A. (2011). Blue nevi and variants: an update. Arch. Pathol. Lab. Med. 135, 327-336.